Telcagepant provides new hope for people with migraine
Research output: Contribution to journal › Debate/Note/Editorial
The triptan drugs provide effective migraine relief for many people. nevertheless, a substantial number of migraine-affected individuals are unresponsive to triptans, and such therapy can also lead to an array of adverse effects. A new class of antimigraine drugs, currently undergoing clinical trials, could offer hope to those for whom triptan medication is unsuitable.
|Research areas and keywords||
Subject classification (UKÄ) – MANDATORY